00455 TIANDA PHARMA
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 0.86X | Oper Margin | N/A |
|---|---|---|---|
| LT Debt/Equity | 0.6% | Net Margin | N/A |
| Total Debt/Equity | 25.2% | Return on Equity | N/A |
| Price/Book | 0.69X | Return on Assets | N/A |
| (HKD 0.163) | 2024-12 | 2023-12 | 2022-12 | 2022-03 | 2021-03 |
| Net Profit (MHKD) | -61.37 | -24.16 | -40.98 | -19.77 | -27.14 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -154.1 | +55.8 | -176.3 | +27.2 | -963.6 |
| Earnings Per Share (HKD) | -0.029 | -0.011 | -0.019 | -0.009 | -0.013 |
| Earnings Per Share Growth (%) | -154.5 | +56.0 | -176.8 | +27.0 | -940.0 |
| Dividend Per Share (HKD) | No dividend | 0.003 | 0.003 | 0.008 | 0.003 |
| P/E* (X) | N/A | N/A | N/A | N/A | N/A |
| Yield (%) | N/A | 1.60 | 2.13 | 5.03 | 1.60 |
| Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
| Book NAV (HKD) | 0.235 | 0.275 | 0.292 | 0.352 | 0.352 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
| (HKDMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
| Cover Period (mths) | 12 | 12 | NA | 9 |
|---|---|---|---|---|
| Turnover | 329.937 | 532.089 | -38.0 | 410.021 |
| Operating Result | -54.34 | -25.835 | +110.3 | -48.824 |
| Profit Before Taxation | -54.34 | -25.694 | +111.5 | -47.89 |
| Taxation | 7.074 | -0.689 | -1,126.7 | -3.647 |
| Profit /( Loss) After Taxation | -61.414 | -25.005 | +145.6 | -44.243 |
| Minority Interests | -0.043 | -0.85 | -94.9 | -3.266 |
| Net Profit | -61.371 | -24.155 | +154.1 | -40.977 |
| Earnings Per Share () | -0.0285 | -0.0112 | +154.5 | -0.0191 |
| Dividend Per Share () | 0.0000 | 0.0026 | -100.0 | 0.0026 |
| Announcement Date | 2025-03-28 | 2024-03-26 | NA | 2023-03-23 |
* Annualised
Last Update Time: 2025-07-22 21:40:25
